Facebook
X
LinkedIn
Forward
Perioperative Continuation of Chronic Opioids and Buprenorphine- (Previously Recorded September 2025 Lunch and Learn)
This monthly learning session addresses the complexities of managing patients on chronic opioid or buprenorphine therapy in the perioperative setting. Participants will explore the rationale behind continuing or adjusting these therapies during surgery, weighing the risks of withdrawal, inadequate pain relief, and drug interactions. The program will outline evidence-based protocols and strategies for managing these patients, encompassing pre-operative assessment, intraoperative adjustments, and tailored post-operative pain management plans. A key focus will be on the importance of interprofessional collaboration and communication, highlighting the need for seamless coordination between anesthesia providers, surgeons, pain specialists, and addiction specialists to ensure optimal patient outcomes.
Target Audience
Iowa Surgical providers
Clinical teams
Learning Objectives
Explain the rationale for continuing or adjusting chronic opioid and buprenorphine therapy in patients undergoing surgical procedures, considering the risks of opioid withdrawal, inadequate analgesia, and potential drug interactions.
Describe evidence-based protocols and strategies for managing patients on chronic opioid or buprenorphine therapy in the perioperative period, including pre-operative assessment, intraoperative adjustments, and post-operative pain management plans.
Discuss the importance of interprofessional collaboration and communication in caring for patients on chronic opioid or buprenorphine therapy undergoing surgery, including coordination between anesthesia providers, surgeons, pain specialists, and addiction specialists.
Additional Information
Rachael Duncan, PharmD BCPS BCCCP
Rachael is a pharmacist and consultant for Stader Opioid Consultants based in Colorado. She has spent the past eight years focused on policy, advocacy, and educational work surrounding harm reduction and substance use disorder treatment at both the state and national level. She serves on the board of directors for the nonprofit The Naloxone Project and is Co-Chair of the MOMs (Maternal Overdose Matters) Initiative, which helps birthing hospitals distribute naloxone directly to at-risk perinatal patients and families. She is also program director for MOMs+, which helps birthing hospitals provide equitable access to treatment and recovery for perinatal patients affected by substance use disorder. Her clinical practice is in hospital-based pharmacy.
Accreditation: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS). Compass Healthcare Collaborative is accredited by the IMS to provide continuing medical education for physicians.
Designation: Compass designates this live activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Commercial Support: This activity was developed without support from any ineligible company. *The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company.
Disclosure: Compass adheres to the Standards for Integrity and Independence in Accredited Continuing Education. The content of this activity is not related to products or the business lines of an ACCME-defined ineligible company. None of the planners or moderators for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing products used by or on patients.
Note: AMA PRA Category 1 Credits™ are accepted for nursing and other healthcare discipline license renewal purposes, provided the topic is relevant to the applicant’s field or discipline. After participating, you will receive a Certificate of Attendance detailing the number of AMA PRA Category 1 Credits™ you can claim. This certificate is provided for self-reporting requirements and must be submitted to your state board for license renewal.
Available Credit
- 0.50 AMA PRA Category 1 Credit™